Advertisement
Advertisement
U.S. markets open in 9 hours 5 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Evoke Pharma, Inc. (EVOK)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.6300-0.1300 (-4.71%)
At close: 04:00PM EDT
Advertisement

Yahoo Finance will soon be upgrading our Conversations message board platform to provide a better experience for our users. Only comments published since April 21, 2021 will be visible on Yahoo Finance after the upgrade. If you wish to download and save any of your older comments, please submit a request via the Privacy Dashboard by no later than Aug. 15, 2022.

Sign in to post a message.
  • P
    Possium
    Please reach $5 soon,,,so I can get out,,,get out,,,get out,,,get out for good !!
  • M
    Mark
    lease up in the fall. they are going to work from their cars for awhile.
  • M
    Mike
    Comparative analysis and incremental growth is looking real good for Evoke.
    Bullish
  • r
    rambo
    23 cents goyner
  • R
    RaoRao
    this is not good
  • M
    Mike
    Scaring investors to sell…..coming soon and stay strong
    Bullish
  • M
    Mark
    PB&J RECONSIDERS EVOKE PHARMA PURCHASE: Says: "Deal looks crumby".
  • r
    rambo
    who could have possibly expected any different. tried to get out a couple times last week. i knew today would be lousy. No advertising and tooooooo......... expensive
  • r
    rambo
    26 days to zero
  • x
    xl
    Market has been coming up so much. Why is this not moving?
  • M
    Mike
    Excellent results coming soon…..
    Bullish
  • p
    peter
    Recommended by the Europe Union for migraines.
    Actual used along side with common pain killers the US emergency rooms in IV injection to treat severe migraine headache ----megafast.
    Clinical proven effective against migraines in combination with common pain killers.
    Recommended as a cheaper alternative to brand name prescribed migraine medications, a $ 37 billion dollars industry.
    And now available in a super fast nasal spray form that eliminates the manic restlessness side effect of the IV injection in minutes.
    Available after years and years of management 'missteps'.
    But only in one supersize and for a superprice.
    Very suspicious that somebody not wanting it in the hands of migraine sufferers.
  • p
    peter
    GSK and Astra Zeneca are 2 biggest makers of migraine drugs in the world. Both are based in the UK. Are you not curious that someone bought up this Gimoti drug that can out compete brand name migraine drugs and then do nothing with it? Even worse, took it to a dead end, somehow managing it as bad as a flying monkey could possibly do?
    If you are 2 sisters going to the ball and you don't want Cinderella to go there then this is exactly what you would do. Shareholders and patients be damned.
  • #
    #1FanPats
    Buyout confirmed. Nicoooooooooooooooooo
  • T
    Thomas
    I just want to be right with my stock pics , got 3 under approval and Pfizer, yawn
    Neutral
  • B
    B
    This stock is a good lesson in hedging your bets with stop losses. It’s a train wreck with a bankruptcy just around the corner. Gonyer will be taken care of, some other company will pick it up for pennies and all you stockholders will be stuffed.
  • x
    xl
    Dropped so much in the past few days. Bad revenue in Q2?
  • p
    peter
    Why are you Munskins so obsessed with revenue? The witch never did care for the sales in the first place. Second half better bla bla bla... She was required by the FDA approval to make available a 7.5 mg dose also and she hasn't done it. Two doses, a 15 mg and a 7.5 mg. Either one could have generated sales!
  • A
    Aussiebat
    EVOK is what we used to call a "boxed" deal meaning very low float that traders were afraid to short because so few shares existed. With such a low float and periodic good news releases a boxed deal could be taken up quite easily. But here we sit unable to move to even the equivalent of .50 cents pre-split or $6 dollars. Heck, EVOK can't even hold $3.50 which is .29 pre-split. Gonyer you can fool some of the retail people some of the time but not all of the retail people all of the time. This is a retail stock and retail people have lost faith in current management which is apparent in the stock price. If I am wrong, then PROVE it!!
  • r
    rambo
    this stock is terminal
Advertisement
Advertisement